Impact of measurement method on interobserver variability of apparent diffusion coefficient of lesions in prostate MRI.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 01 10 2021
accepted: 09 05 2022
entrez: 23 5 2022
pubmed: 24 5 2022
medline: 26 5 2022
Statut: epublish

Résumé

To compare the inter-observer variability of apparent diffusion coefficient (ADC) values of prostate lesions measured by 2D-region of interest (ROI) with and without specific measurement instruction. Forty lesions in 40 patients who underwent prostate MR followed by targeted prostate biopsy were evaluated. A multi-reader study (10 readers) was performed to assess the agreement of ADC values between 2D-ROI without specific instruction and 2D-ROI with specific instruction to place a 9-pixel size 2D-ROI covering the lowest ADC area. The computer script generated multiple overlapping 9-pixel 2D-ROIs within a 3D-ROI encompassing the entire lesion placed by a single reader. The lowest mean ADC values from each 2D-small-ROI were used as reference values. Inter-observer agreement was assessed using the Bland-Altman plot. Intraclass correlation coefficient (ICC) was assessed between ADC values measured by 10 readers and the computer-calculated reference values. Ten lesions were benign, 6 were Gleason score 6 prostate carcinoma (PCa), and 24 were clinically significant PCa. The mean±SD ADC reference value by 9-pixel-ROI was 733 ± 186 (10-6 mm2/s). The 95% limits of agreement of ADC values among readers were better with specific instruction (±112) than those without (±205). ICC between reader-measured ADC values and computer-calculated reference values ranged from 0.736-0.949 with specific instruction and 0.349-0.919 without specific instruction. Interobserver agreement of ADC values can be improved by indicating a measurement method (use of a specific ROI size covering the lowest ADC area).

Identifiants

pubmed: 35604891
doi: 10.1371/journal.pone.0268829
pii: PONE-D-21-31701
pmc: PMC9126398
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0268829

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Eur Radiol. 2019 May;29(5):2243-2245
pubmed: 30488105
Abdom Imaging. 2015 Oct;40(8):3214-21
pubmed: 26156619
Eur Urol. 2016 Jan;69(1):41-9
pubmed: 26361169
Eur Radiol. 2020 Dec;30(12):6582-6592
pubmed: 32594208
Eur Urol Oncol. 2020 Aug;3(4):489-497
pubmed: 31412009
Radiology. 2014 Apr;271(1):143-52
pubmed: 24475824
Acad Radiol. 2022 Aug;29(8):1159-1168
pubmed: 34598869
Eur Urol. 2019 Sep;76(3):340-351
pubmed: 30898406
AJR Am J Roentgenol. 2020 Jul;215(1):133-141
pubmed: 32160050
Radiology. 2008 Dec;249(3):900-8
pubmed: 19011187
Radiology. 2014 Feb;270(2):454-63
pubmed: 24471390
Radiology. 2008 Nov;249(2):624-30
pubmed: 18936317
AJR Am J Roentgenol. 2019 Jan;212(1):109-116
pubmed: 30383404
AJR Am J Roentgenol. 2018 Jan;210(1):113-117
pubmed: 29045185
Eur Urol Oncol. 2018 May;1(1):29-36
pubmed: 31100225
AJR Am J Roentgenol. 2014 Mar;202(3):W247-53
pubmed: 24555621
Med Phys. 2021 Nov;48(11):6889-6900
pubmed: 34418108
AJR Am J Roentgenol. 2014 Sep;203(3):W287-94
pubmed: 25148186
Diagn Interv Radiol. 2013 Nov-Dec;19(6):433-7
pubmed: 24004973
J Digit Imaging. 2019 Aug;32(4):571-581
pubmed: 31089974
Clin Cancer Res. 2014 Jul 15;20(14):3705-11
pubmed: 24850842
Radiology. 2017 Apr;283(1):119-129
pubmed: 27783538
Abdom Radiol (NY). 2020 Dec;45(12):3951-3960
pubmed: 32185445
Abdom Radiol (NY). 2017 Sep;42(9):2340-2345
pubmed: 28396920
Eur Urol. 2016 Jan;69(1):16-40
pubmed: 26427566

Auteurs

Hiroaki Takahashi (H)

Department of Radiology, Mayo Clinic, Rochester, Minnesota, United States of America.

Kotaro Yoshida (K)

Department of Radiology, Kanazawa University School of Medical Science, Ishikawa, Japan.

Akira Kawashima (A)

Department of Radiology, Mayo Clinic, Rochester, Arizona, United States of America.

Nam Ju Lee (NJ)

Department of Radiology, Mayo Clinic, Rochester, Minnesota, United States of America.

Adam T Froemming (AT)

Department of Radiology, Mayo Clinic, Rochester, Minnesota, United States of America.

Daniel A Adamo (DA)

Department of Radiology, Mayo Clinic, Rochester, Minnesota, United States of America.

Ashish Khandelwal (A)

Department of Radiology, Mayo Clinic, Rochester, Minnesota, United States of America.

Candice W Bolan (CW)

Department of Radiology, Mayo Clinic, Rochester, Florida, United States of America.

Matthew T Heller (MT)

Department of Radiology, Mayo Clinic, Rochester, Arizona, United States of America.

Robert P Hartman (RP)

Department of Radiology, Mayo Clinic, Rochester, Minnesota, United States of America.

Bohyun Kim (B)

Department of Radiology, Mayo Clinic, Rochester, Minnesota, United States of America.

Kenneth A Philbrick (KA)

Department of Radiology, Mayo Clinic, Rochester, Minnesota, United States of America.

Rickey E Carter (RE)

Department of Health Science Research, Mayo Clinic, Rochester, Florida, United States of America.

Lance A Mynderse (LA)

Department of Urology, Mayo Clinic, Rochester, Minnesota, United States of America.

Mitchell R Humphreys (MR)

Department of Urology, Mayo Clinic, Rochester, Arizona, United States of America.

Jason C Cai (JC)

Department of Radiology, Mayo Clinic, Rochester, Minnesota, United States of America.

Naoki Takahashi (N)

Department of Radiology, Mayo Clinic, Rochester, Minnesota, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH